Reported Aug 14, 2019 · Terminated
Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per…
RXQ Compounding LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: RXQ Compounding LLC · 340 W State St Unit 9 · Athens, OH · 45701-1564
Is this the product you have?
Avastin25MG/ML Syringe[a) 0.1 mL NDC 70731-0197-91b) 0.12 mL NDC 70731-0197-92c) 0.15 mL NDC 70731-0197-93] per vialRXQ Compounding340 West State StreetUnit 9AthensOH 45701
- Lot codes and dates
- All lots within expiry
- Amount recalled
- N/A
This recall covers 86 products
The agency filed one notice per product. You are reading one of them; the other 85 are below.
73 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new RXQ Compounding LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.